IRINOTECAN WITH BIWEEKLY, LOW DOSE LEUCOVORIN AND BOLUS AND CONTINUOUS INFUSION 5-FLUOROURACIL (MODIFIED FOLFIRI) AS FIRST LINE THERAPY FOR PATIENTS WITH RECURRENT OR METASTATIC GASTRIC CANCER

被引：0
|
作者：
Oh, S. Y. [1 ]
Kim, B. G. [1 ]
Kwon, H. [1 ]
Lee, S. [1 ]
Lee, D. M. [1 ]
Jang, J. S. [1 ]
Kim, M. C. [1 ]
Kim, S. [1 ]
Kim, H. [1 ]
机构：
[1] Dong A Univ, Coll Med, Pusan, South Korea
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：183 / 183
页数：1
相关论文
共 50 条
  • [41] Low dose calcium leucovorin with continuous 5-fluorouracil infusion: A clinical study
    Weiss, AJ
    Simoes, A
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 9 (01) : 25 - 28
  • [42] 5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) as a third-line chemotherapy treatment in metastatic gastric cancer, after failure of fluoropyrimidine, platinum, anthracycline, and taxane
    Erdem, Gokmen Umut
    Bozkaya, Yakup
    Ozdemir, Nuriye Yildirim
    Demirci, Nebi Serkan
    Yazici, Ozan
    Zengin, Nurullah
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2018, 18 (02) : 170 - 177
  • [43] A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer
    Van Cutsem, E
    Pozzo, C
    Starkhammar, H
    Dirix, L
    Terzoli, E
    Cognetti, E
    Humblet, Y
    Garufi, C
    Filez, L
    Gruia, G
    Cote, C
    Barone, C
    ANNALS OF ONCOLOGY, 1998, 9 (11) : 1199 - 1204
  • [44] Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma
    Chung, YS
    Yamashita, Y
    Inoue, T
    Matsuoka, T
    Nakata, B
    Onoda, N
    Maeda, K
    Sawada, T
    Kato, Y
    Shirasaka, T
    Sowa, M
    CANCER, 1997, 80 (01) : 1 - 7
  • [45] Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin in patients with advanced gastric cancer
    Sym, Sun Jin
    ANNALS OF ONCOLOGY, 2006, 17 : 315 - 315
  • [46] Biweekly oxaliplatin in combination with continuous infusional 5-fluorouracil and leucovorin (modified FOLFOX-4 regimen) as first-line chemotherapy for elderly patients with advanced gastric cancer
    Liu, Zhi-Fang
    Guo, Qi-Sen
    Zhang, Xi-Qin
    Yang, Xi-Gui
    Guan, Fang
    Fu, Zheng
    Wang, Ming-Yu
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (03): : 259 - 263
  • [47] Paclitaxel, oxaliplatin, 5-fluorouracil and leucovorin combination chemotherapy in patients with recurrent or metastatic gastric cancer
    Lan, Yan-qin
    Wu, Ri-ping
    Huang, Xiao-bing
    Wang, Xin-li
    Zhong, Dong-ta
    Huang, Chuan-yong
    Song, Jin-tian
    TUMORI JOURNAL, 2018, 104 (01): : 22 - 29
  • [48] A phase II study of irinotecan, oxaliplatin, 5-fluorouracil, leucovorin (FOLFOXIRI) as a first-line chemotherapy in metastatic gastric cancer.
    Lee, J.
    Kang, W.
    Lee, S.
    Kwon, J.
    Kim, H.
    Lee, H.
    Lim, H.
    Park, J.
    Park, Y.
    Park, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 197S - 197S
  • [49] Bevacizumab in combination with irinotecan, 5-fluorouracil and leucovorin given as first-line treatment of metastatic colorectal cancer
    Rocha, Jose Aurillo
    ANTI-CANCER DRUGS, 2011, 22 : S9 - S13
  • [50] A randomized phase II study of biweekly irinotecan monotherapy or a combination of irinotecan plus 5-fluorouracil/leucovorin (mFOLFIRI) in patients with metastatic gastric adenocarcinoma refractory to or progressive after first-line chemotherapy
    Sun Jin Sym
    Junshik Hong
    Jinny Park
    Eun Kyung Cho
    Jae Hoon Lee
    Yeon Ho Park
    Woon Ki Lee
    Min Chung
    Hyung-Sik Kim
    Se Hoon Park
    Dong Bok Shin
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 481 - 488
12345